Abstract
Cancer patients are simultaneously at an increased risk of venous thromboembolic complications and a high risk of bleeding. The decision to conduct thromboprophylaxis in oncology patients should be based on an assessment of the individual risk of thrombosis and major bleeding.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have